NCT03200769View on ClinicalTrials.gov

Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

July 21, 2014

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Sleep Apnea SyndromesEpilepsies, Partial
Interventions
DEVICE

CPAP active

CPAP PR1 Philips Respironics with a pression between 4 and 14 mm Hg

DEVICE

CPAP placebo

CPAP PR1 Philips Respironics with a constant pression of 4 mm Hg.

Trial Locations (1)

59037

CHRU de Lille - Rue Emile LAINE - Hopitâl Roger Salengro Rez de Chaussée - Neurophysiologie Clinique, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT03200769 - Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy | Biotech Hunter | Biotech Hunter